International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 4 , Pages 971-973 , 15 March 2009

Histologic Response Grading After Chemoradiation in Locally Advanced Rectal Cancer: A Proposal for Standardized Reporting

  • Rob Glynne-Jones, FRCR., FRCP.

      Affiliations

    • Corresponding Author InformationReprint requests: Dr. Rob Glynne-Jones, Mount Vernon Centre for Cancer Treatment, Northwood, Middlesex, United Kingdom HA6 2RN. Tel: 0044 1923 844767; Fax: 0044 1923 844960
    • ,
  • Nicola Anyemene, FRCR., MRCP.

Received 17 June 2008 ,Revised 2 October 2008 ,Accepted 19 October 2008.

References 

  1. Rich TA, Skibber JM, Ajani JA. Preoperative infusional chemoradiation therapy for stage III rectal cancer. Int J Radiat Oncol Biol Phys. 1995;32:1025–1029
  2. Dolinsky CM, Mahmoud NN, Mick R, et al. Effect of time interval between surgery and preoperative chemoradiotherapy with 5-Fluorouracil or 5-Fluorouracil and oxaliplatin on outcomes in rectal cancer. J Surg Oncol. 2007;96:207–212
  3. Bouzourene H, Bosman FT, Seelentag W. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer. 2002;94:1121–1130
  4. Mandard AN, Dalibar DF, Mandard JC. Pathological assessment of tumor regression after preoperative chemoradiotherapy of oesophageal carcinoma: Clinico-pathologic correlations. Cancer. 1994;73:2680–2686
  5. Becker K, Mueller JD, Schulmacher C, et al. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer. 2003;98:1521–1530
  6. Sauer R, Becker H, Hohenberger W, et al. German Rectal Cancer Study Group Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–1740
  7. Francois Y, Nemoz CJ, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and the rate of sphincter-saving surgery for rectal cancer: The Lyon R90-01 randomized trial. J Clin Oncol. 1999;17:2396–2402
  8. Wheeler JMD, Warren BF, Mortensen NJM. Qualification of histologic regression of rectal cancer after irradiation: A proposal for a modified staging system. Dis Colon Rectum. 2002;45:1051–1056
  9. Rodel C, Martus P, Papadopoulos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005;23:8688–8696
  10. Ryan R, Gibbons D, Hyland JM, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47:141–146

 Honoraria received from Roche, Sanofi-Aventis, Merck Serono, and Pfizer for attendance at advisory boards, speakers' bureau, and support received to attend international meetings (all less than $10,000) (R.G.-J.).

 Conflict of interest: none.

PII: S0360-3016(08)03745-0

doi: 10.1016/j.ijrobp.2008.10.056

International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 4 , Pages 971-973 , 15 March 2009

Article Tools